Long-Term Outcomes of Rituximab Therapy in Autoimmune Hemolytic Anemia: A Systematic Review and Meta-Analysis.

Saved in:
Bibliographic Details
Title: Long-Term Outcomes of Rituximab Therapy in Autoimmune Hemolytic Anemia: A Systematic Review and Meta-Analysis.
Authors: Rizwanullah U; Internal Medicine, Hayatabad Medical Complex Peshawar, Peshawar, PAK., Abifaraj A; Medicine and Surgery, Universidad Catolica de Honduras, San Pedro Sula, HND., Shah S; Medicine, Caribbean Medical University School of Medicine, Willemstad, CUW., Kausar R; Internal Medicine, Ross University School of Medicine, Bridgetown, BRB., Hummad H; Anesthesia and Critical Care, College of Applied Medical Sciences, Khamis Mushait, King Khalid University, Abha, SAU., Portillo Muñoz CA; Medicine and Surgery, Universidad Nacional Autonoma de Honduras, San Pedro Sula, HND., Hyderi FA; Internal Medicine, Bangladesh Medical College, Bangladesh Medical Studies and Research Institute (BMSRI), Dhaka, BGD., Chi Gomez LA; Medicine and Surgery, Universidad Nacional Autonoma de Honduras, San Pedro Sula, HND., Urbina R; Internal Medicine, Universidad Catolica de Honduras, San Pedro Sula, HND., Niftalieva G; Medicine, Donetsk National Medical University, Donetsk, UKR., Vasquez Zelaya ED; Medicine and Surgery, Universidad Nacional Autonoma de Honduras, San Pedro Sula, HND., Faraj M; Clinical Research, Wayne State University Detroit Medical Center, Detroit, USA.
Source: Cureus [Cureus] 2025 May 12; Vol. 17 (5), pp. e83962. Date of Electronic Publication: 2025 May 12 (Print Publication: 2025).
Publication Type: Journal Article; Review
Journal Info: Publisher: Cureus, Inc Country of Publication: United States NLM ID: 101596737 Publication Model: eCollection Cited Medium: Print ISSN: 2168-8184 (Print) Linking ISSN: 21688184 NLM ISO Abbreviation: Cureus Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2168-8184
DOI:10.7759/cureus.83962